Immunotherapy company developing next-generation, transformative therapies for the treatment of solid tumors and other immune-mediated diseases in broad.
Outcomes4Me Inc., a Cambridge, Mass.-based developer of an Artificial Intelligence (AI)-powered platform to empower cancer patients to navigate their care, raised $12m in Series A funding round.
The round was led by Northpond Ventures, with participation from all existing investors, including Sierra Ventures, Asset Management Ventures, Merstal Ltd, IRA Capital, and others. Andrea Jackson, a Northpond Ventures Director, will join Outcomes4Me’s board.
The company intends to use the funds to extend its platform beyond breast cancer to other cancers, grow the platform’s regulatory-grade dataset, and expand to more patients in Europe.
Co-founded in 2017 by Maya R. Said, Sc. D., CEO, and Dr. Osama Rahma, Chief Medical Advisor, who were later joined by Chief Operating Officer Sami Shalabi, a former Google executive who sold his company to Google and co-founded and led Google Play Newsstand and the all-new Google News, growing both to over a billion users, Outcomes4Me has dev